Crenessity - Crinecerfont 25 mg / 1 Capsule 60 Capsule

Reference details for licensed healthcare facility review and verification.

crinecerfont NDC Family 70370-5025 crinecerfont 25 mg / 1

NDC 11	70370-5025-01
Product NDC	70370-5025
Generic Drug Name	crinecerfont
Brand Name	Crenessity
Manufacturer	Neurocrine Biosciences, Inc.
Strength	25 mg / 1
Dosage Form	Capsule
Drug Type	Oral
Package Quantity	60 Capsule
Package Description	60 CAPSULE in 1 BOTTLE (70370-5025-1)
Active Ingredients	Crinecerfont
Marketing Category	NDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

Reference only: This listing is designed to assist product identification and quote review for licensed healthcare facilities. It does not imply manufacturer endorsement, sponsorship, or direct purchasing status.

Request a Quote Review

Start a quote review for this exact presentation or send a product-specific inquiry. We can combine multiple items into one response for licensed healthcare buyers.

Quote Requests Drug Search

Instructions

Click "Add to Quote Request" to add this item and open your quote request.
Continue browsing and add additional products from other exact NDC detail pages if needed.
Submit one quote request with your organization details and required quantities.
You can review or submit at any time from Quote Request.

Licensing requirement: Quote and fulfillment of prescription pharmaceutical products require valid state and federal licensure and related documentation, where applicable.

Quote Review Form

NDC snapshot

crinecerfont 25 mg / 1 Capsule is tracked under NDC 70370-5025-01 and rolls up into product family 70370-5025. Use this page to confirm the exact presentation before comparing related family pages or starting a quote review.

Package configuration: 60 Capsule.
Manufacturer: Neurocrine Biosciences, Inc..
Dosage form: Capsule.
Family size: 1 indexed presentation.

Click a tag to refine the catalog view around this exact presentation.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Search DailyMed labelingOpens DailyMed search results.

Crenessity - Crinecerfont 25 mg / 1 Capsule 60 Capsule, NDC 70370-5025-01, is a Neurocrine Biosciences, Inc. 25 mg / 1 capsule presentation packaged as 60 Capsule.

NDC search formats

Canonical NDC 11: 70370-5025-01
Digits-only NDC 11: 70370502501
Possible 10-digit display format: 70370-5025-1 (7037050251)

Helpful product links

Search by brand name: Crenessity
Exact NDC 11: 70370-5025-01
Product family NDC: 70370-5025
VA classification code: HS900
VA classification code description: HORMONES/SYNTHETICS/MODIFIERS,OTHER
CMOP ID: C2156
VUID: 4044049